Molnupiravir

  • Covid-19 News

    CCSA spokesperson says 30,000 Covid infections per day

    The Centre for Covid-19 Situation Administration spokesperson is warning that Covid-19 infections are growing, with an increase seen in 44 of Thailand’s 77 provinces, including Bangkok. He said that between August 7 and August 13, daily Covid infections had averaged 31,148 cases per day, despite the Department of Disease Control reporting official numbers of about 1,900 infections today and 2,100…

  • Covid-19 News

    Authorities warn: Don’t self-prescribe Covid drugs like Molnupiravir

    New warnings are being issued about self-medicating or misusing Covid-19 drugs like Molnupiravir and the negative effects that could result from it. Department of Disease Control Director-General Dr Opas Karnkawinpong is warning that people who do not need treatment taking antiviral drugs may create drug resistance in their body, making it ineffective against future infections. Meanwhile, director of King Chulalongkorn…

  • Covid-19 News

    Molnupiravir should not be bought online and used, FDA warns

    Self-administering the Covid-19 drug Molnupiravir can be dangerous, according to a new warning by the Thai Food a Drug Administration. The FDA announced that people should not purchase Molnupiravir independently and should only take the drug that has been used to treat Covid symptoms after consultation with a doctor or other medical professional who can prescribe proper usage. The Secretary…

  • Thailand News

    Thai health chief received special drug due to obesity, not privilege

    A Thai doctor and netizens have questioned the Covid-19 treatment plan in Thailand after the Deputy PM and Public Health Minister Anutin Charnvirakul received a Molnupiravir shot even though he only had mild symptoms. The Department of Medical Services insisted that no special privileges were involved and the politician received the vaccine because he is considered to be in a…

  • Thailand video news

    Thailand News Today | More competition for thai taxis!

    A leading epidemiologist has questioned Thailand’s rush to declare Covid endemic as infections and deaths surge. Dr. Chakrarat, director of the Bureau of Epidemiology, is suggesting officials slow down a bit, as he casts doubt on the wisdom of trying to declare the virus endemic by July 1. Despite raising the country’s alert level to level 4 on February 21,…

  • Thailand video news

    Thailand News Today | Water fights are banned for Songkran this year

    It might soon get a little easier to travel to Thailand. The government plans to scrap the pre-departure testing requirements for vaccinated travellers entering the country under the Test & Go and Sandbox schemes. A spokesperson says they are waiting for confirmation.   Under the planned revisions, a PCR test is needed on arrival and a self-administered rapid antigen test…

  • Covid-19 News

    Medical expert calls for transition from favipiravir to more effective molnupiravir

    A leading health professional says Thailand should phase out the use of favipiravir, saying molnupiravir is a more effective Covid-19 treatment. Dr Opass Putcharoen, from the Thai Red Cross Emerging Infectious Diseases Clinical Centre, says this will be essential as the country moves to declaring Covid-19 endemic. He added that the cost of molnupiravir produced in India is somewhere between 600…

  • Covid-19 News

    Omicron stabilising, officials consider easing Covid-19 restrictions

    While infections of the Omicron variant of Covid-19 have caused a sharp rise in the daily statistics, deaths and even hospitalisations have not been as affected, causing the Ministry of Public Health to call for an easing of Covid-19 restrictions. Numbers of fatalities, as well as those on ventilators and in ICUs still remain low, says Minister of Public Health…

  • Covid-19 News

    Thailand signs procurement deal for 50,000 courses of Molnupiravir Covid pill

    Thailand has signed a 500 million baht deal to purchase 50,000 treatment courses of the new Covid-19 drug, Molnupiravir. According to a Thai PBS World report, the Medical Services Department signed the deal yesterday, with Health Minister Anutin Charnvirakul present to witness it. A course of treatment is made up of 40 x 200mg capsules. A patient will need to…

  • Covid-19 News

    Covid-19 medications are a boon, but don’t replace vaccines

    The good news of several new anti-viral pills that have shown to be effective in greatly reducing Covid-19 hospitalisations and deaths, coupled with statistically rare vaccine side effects or deaths that some people latch onto, may tempt many to skip getting vaccinated and rely solely on medication once they get infected. But a Thai expert on crisis communication with the…

  • Covid-19 News

    Thai Cabinet gives the green light for procurement of Molnupiravir

    The Thai Cabinet has given the go-ahead for the Public Health Ministry to purchase 50,000 treatment courses of the antiviral pill, Molnupiravir. The drug, from US manufacturer Merck, is the world’s first oral treatment for Covid-19 and has been shown to cut the risk of hospitalisation if administered within days of symptoms developing. According to a Bangkok Post report, Health…

  • Covid-19 News

    Thai government to stock up on new Covid-19 treatments

    Thailand’s Public Health Ministry plans to order 2 types of antiviral oral treatment in its fight against Covid-19. The Bangkok Post reports that the ministry wants to order supplies of the Molnupiravir antiviral pill, as well as Pfizer’s new oral treatment, Paxlovid. Dr Atthasit Srisubat from the Department of Medical Services has confirmed the decision, following the recent order from PM…

  • Covid-19 News

    Paxlovid by Pfizer reduces Covid-19 hospitalisation, death by 89%

    Hot on the tail of Merck winning approval for use in the UK for its anti-viral Molnupiravir pill treatment, Pfizer announced yesterday that clinical trials show their new drug, Paxlovid, to be highly effective in treating Covid-19. The pharmaceutical giant was quick to point out that their pill was developed with the specific goal of fighting Covid-19, unlike the Merck…

  • Covid-19 News

    Britain the first to approve Covid-19 antiviral pill Molnupiravir

    Molnupiravir, the antiviral pill that fights Covid-19, has just been approved for use in Britain, the first country in the world to do so. The pill was developed by Merck and Ridgeback Biotherapeutics and has been shown to reduce the severity of symptoms in patients infected with Covid-19. The drug is recommended to be used as soon as possible after a…

  • Covid-19 News

    Thailand deemed too wealthy to produce generic Molnupiravir

    Thailand has been deemed to be too rich to produce a generic version of the anti-viral drug Molnupiravir that reduces the negative effects of Covid-19 infections. Merck, the producer of the drug, had made an agreement to license the virus-fighting drug to production companies in poor countries to help in dealing with the Covid-19 pandemic. But the World Bank has…

  • Thailand News

    PM says cooperation needed as Thailand prepares for reopening

    PM Prayut Chan-o-cha has stressed the importance of public and business cooperation ahead of next week’s reopening of Thailand’s borders and the relaxing of quarantine requirements for international visitors. The Bangkok Post has reported Prayut has asked for strict compliance with disease controls, and that protesters do not damage the national image, paving the way for a successful reopening. Prayut,…

  • Covid-19 News

    Thammasat University negotiates multiple deals for vaccines

    A new deal has been struck between 2 private hospitals and Thammasat University to purchase and import 5 million Pfizer and Moderna mRNA vaccines. This is an addition to a recently negotiated deal to procure 2 million modern vaccines, making a total of 7 million doses that the school will help bring into Thailand after recently being approved by the…

  • Covid-19 News

    Health Ministry’s plan to purchase new Covid-19 treatment pill gets the green light

    Yesterday, the CCSA approved a proposal from the Public Health Ministry to procure a new oral treatment for Covid-19. The ministry plans to purchase 50,000 courses of the anti-viral Molnupiravir drug developed by pharmaceutical firm Merck. The proposal now goes to Cabinet for final approval. The news was confirmed by CCSA spokesman, Dr Taweesin Visanuyothin, who would not be drawn…

  • Covid-19 News

    Covid-19 drug likely to arrive December as procurement agreement in final stages

    The world’s first oral treatment for Covid-19 could be available in Thailand from December, as a draft agreement nears completion. According to a Bangkok Post report, the Department of Medical Services chief says the draft procurement deal is awaiting legal approval from the government. Somsak Akksilp says his department is in talks with the Thai subsidiary of pharmaceutical giant Merck,…

  • Covid-19 News

    Thailand to finalise procurement contract for new Covid-19 drug within 2 weeks

    The Health Ministry says a contract to purchase supplies of the first oral Covid-19 treatment will be completed in the next 2 weeks. According to a Bangkok Post report, the first batch of pills could arrive as soon as November. Somsak Akkasilp from the Department of Medical Services says the government has ordered enough to treat 200,000 people, adding that…